skip to content
2009 Research Festival Artwork

   Home > Concurrent Symposia Sessions > Antibody-based Therapies for Human Disease

Concurrent Symposia Sessions

Wednesday, October 7, 2009
Natcher Conference Center
Symposia Session II
Balcony C

Antibody-based Therapies for Human Disease
9:00 a.m. - 11:00 a.m

Co-Chairs: David FitzGerald, NCI and Mitchell Ho, NCI

Antibodies are important agents for both the therapy and diagnosis of human disease. Therapeutic antibodies are currently used in the treatment of cancer, infectious disease and inflammatory processes. Advances in antibody engineering are aimed at improving early generation antibodies and by using recombinant techniques, display selections and mutagenesis, it is hoped to generate antibodies with more desirable properties.


Presentation by FARE Award Winner
Affect of Bevacizumab on Glioblastoma Vascularity as Assessed with Dynamic Contrast-enhanced MRI
Weiting Zhang, NCI

David FitzGerald, NCI

Recombinant Immunotoxins for Treating Cancer
Ira Pastan, NCI

Engineered Antibody Domains as Candidate Therapeutics
Dimiter Dimitrov, NCI

Antibodies that Neutralize Cytokines
Warren Strober, NIAID

Human Monoclonal Antibodies to Mesothelin
Mitchell Ho, NCI

Back to the top